YOLFTbeta
Memphasys Ltd

Memphasys Ltd

MEM · AU · Healthcare / Medical Devices

0.004AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.004
Open0.004
Day Range0.004 – 0.004
52-Week Range0.003 – 0.009
Volume708.59K
Market Cap15.48M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.46
50-Day Avg0.006
200-Day Avg0.006

About

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, an in-vitro diagnostic device; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOProf. R. John Aitken Ph.D., ScD FRSE
  • Employees0
  • Headquarters34-36 Richmond Road, Homebush, NSW, Australia, 2140, Australia
  • Websitehttps://www.memphasys.com

Leadership

  • Prof. R. John Aitken Ph.D., ScD FRSEScientific Director
  • Mr. Stefan RossCompany Secretary

Financials

Income Statement

Currency: AUD2007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue791.00K1.61M2.17M5.37M1.80M2.55M918.65K850.86K79.90K63.96K0000211.48K27.15K15.37K60.00K526.92K273.79K
Growth (%)-+103.65%+34.53%+147.99%-66.51%+41.66%-63.97%-7.38%-90.61%-19.95%-100.00%-----87.16%-43.38%+290.35%+778.20%-48.04%
Cost of Revenue943.00K1.48M1.12M921.90K684.55K944.53K862.93K700.39K57.99K19.45K20.70K20.95K8.92K196.23K259.49K949.75K840.23K1.63M95.86K1.80M
Gross Profit-127.91K1.05M4.45M1.12M1.60M55.72K150.46K21.91K44.51K-20.70K-20.95K-8.92K-196.23K-48.00K-922.60K-824.86K-1.57M431.06K-1.52M
Gross Margin-7.94%48.34%82.85%61.96%62.95%6.07%17.68%27.42%69.60%-----22.70%-3398.41%-5366.35%-2613.69%81.81%-556.14%
Operating Expense-6.52M4.54M5.20M6.10M5.98M3.26M1.75M1.66M1.82M2.09M1.15M1.07M1.07M1.65M553.09K2.81M3.67M3.00M2.63M
Operating Income--6.39M-3.49M-750.04K-4.98M-4.37M-3.21M-1.60M-1.64M-1.77M-2.11M-1.17M-1.08M-1.26M-1.69M-1.48M-3.63M-5.24M-2.57M-4.15M
Operating Margin--396.93%-161.21%-13.96%-276.95%-171.43%-349.04%-187.65%-2048.98%-2773.54%-----800.78%-5435.70%-23640.75%-8731.22%-486.89%-1516.75%
EBITDA--4.82M-2.13M3.77M-5.44M-5.77M-1.96M-624.83K-1.62M-1.83M-1.75M-103.21K-988.32K-869.05K-1.14M-1.39M-2.36M-4.24M-2.57M-3.56M
EBITDA Margin--299.01%-98.47%70.20%-302.11%-226.31%-213.88%-73.44%-2024.28%-2860.00%-----537.83%-5116.68%-15363.87%-7061.72%-486.89%-1300.17%
Net Income--5.50M-2.74M3.29M-6.56M-4.92M-1.84M-3.84M-2.36M-2.17M-2.00M-401.16K-1.04M-1.13M-1.49M-2.08M-3.40M-4.44M-4.94M-4.10M
Net Income Margin--341.19%-126.39%61.25%-364.70%-193.14%-200.50%-451.56%-2953.72%-3400.13%-----702.86%-7668.94%-22136.61%-7403.37%-937.88%-1498.73%
R&D906.00K2.52M-5.52K404.44K900.72K864.24K513.85K207.71K178.57K137.59K181.11K196.90K113.29K466.26K1.09M1.47M2.14M1.29M979.70K
R&D as % of Total Revenue114.54%156.46%-0.10%22.47%35.33%94.08%60.39%259.96%279.19%----220.47%4012.69%9558.87%3564.34%245.68%357.82%
Interest Expense0264.23K198.11K111.99K5.51K68.22K347.84K521.83K682.30K326.01K129.67K276.99K47.33K68.60K89.51K569.68K428.20K417.13K585.42K383.82K
Interest Expense % of Total Revenue0.00%16.40%9.14%2.08%0.31%2.68%37.86%61.33%853.95%509.72%----42.33%2098.41%2785.75%695.22%111.10%140.19%

Balance Sheet

Currency: AUD2007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets4.46M5.06M5.76M17.72M10.57M8.95M13.63M7.10M6.84M7.19M7.30M4.22M6.84M11.30M14.58M14.12M14.67M12.43M11.02M11.24M
Total Liabilities2.66M3.95M6.16M4.87M3.58M4.39M6.64M8.10M6.10M5.72M7.70M865.59K765.00K1.54M5.97M6.47M7.28M5.59M5.65M7.02M
Total Equity1.80M1.10M-398.47K12.84M7.00M4.56M1.82M-992.85K746.59K1.48M-402.24K3.35M6.07M9.76M8.61M7.65M7.38M6.84M5.37M4.21M
Cash209.00K695.56K33.40K1.20M29.01K173.45K180.94K84.40K174.78K19.00K2.35K201.81K873.57K2.01M2.05M311.83K680.58K277.80K298.30K1.18M
Total Debt-1.36M401.80K100.00K377.29K1.07M2.05M6.72M5.37M4.89M6.74M482.04K6.75K1.07M5.36M5.56M6.37M4.81M5.11M4.24M
Net Debt-661.61K368.40K-1.10M348.28K894.98K1.87M6.63M5.20M4.87M6.74M280.23K-866.83K-943.31K3.31M5.25M5.69M4.53M4.81M3.07M

Cash Flow

Currency: AUD2007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--4.00M400.62K-2.63M-1.70M-655.09K-987.97K-941.64K-2.42M-1.27M-1.23M-738.42K-707.47K120.19K44.71K311.82K-1.41M-3.23M-2.41M-2.49M
Investing Cash Flow-34.22K-1.19M-3.02M-2.19M-2.40M-1.62M-1.64M702.43K-740.56K-621.43K-1.23M-2.12M-3.14M-3.00M-3.08M-1.98M-711.05K-673.28K-3.38K
Financing Cash Flow2.73M4.45M121.26K6.82M2.72M3.22M2.61M2.48M1.85M1.86M1.83M2.17M3.50M4.11M2.99M1.03M3.75M3.54M3.15M3.37M
Capital Expenditure99.00K98.49K2.13M1.20M2.19M2.40M1.69M166.31K18.33K5.08K664.73K2.40K13.70K3.14M3.00M2.92M1.82M638.26K43.38K
Free Cash Flow--4.10M-1.73M-3.83M-3.89M-3.06M-2.68M-1.11M-2.44M-1.28M-1.89M-740.82K-721.17K-3.02M-2.96M-2.61M-3.23M-3.87M-2.41M-2.49M
Dividends Paid---------00--3.77M2.97M1.09M849.00K---
FCF to OCF-102.46%-432.41%145.61%229.23%467.12%271.17%117.66%100.76%100.40%154.11%100.33%101.94%-2510.51%-6619.66%-837.44%229.53%119.75%100.00%100.14%
Dividend Paid to FCF---------0.00%0.00%---125.00%-100.50%-41.73%-26.30%---

Earnings

Report DateFeb 3, 2016Sep 28, 2016Feb 28, 2017Sep 29, 2017Feb 23, 2018Aug 27, 2018Feb 27, 2019Aug 28, 2019Feb 25, 2020Aug 27, 2020Feb 26, 2021Aug 30, 2021Feb 25, 2022Aug 31, 2022Feb 24, 2023Feb 28, 2025Sep 30, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.000.000.000.00-0.010.000.000.000.000.000.000.000.000.000.000.00
Surprise-----------------
Timing-------------After-hoursAfter-hours--

Key Statistics & Ratios

Market Cap15.48M
Enterprise Value18.53M
Trailing P/E0.00
Forward P/E0.00
Price / Sales23.52
Price / Book3.67
EPS0.00
Book Value0.001
Revenue (TTM)657.97K
Gross Profit (TTM)355.46K
EBITDA-2.93M
Profit Margin0.00%
Operating Margin-201.47%
Return on Equity-95.94%
Return on Assets-16.65%
Shares Outstanding3.10B
Shares Float1.87B
Beta0.46
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 16, 20181:15
  • Sep 26, 20113:2
  • Mar 15, 20091:20